Persistence of immune response after hepatitis B vaccination in medical students and residents

Archives of Iranian Medicine

Volumn 7, Issue 1, 2004, Pages 37-40

  Moghaddam, Sodaif Darvish ^a,b   Zahedi, Mohammad Javad ^a   Yazdani, Rostam ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hepatitis B vaccination; Immune response; Medical students; Residents

Indexed keywords

HEBERBIOVAC HB; HEPATITIS B SURFACE ANTIBODY; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; INOCULATION; MALE; MEDICAL STUDENT; NORMAL HUMAN; RESIDENT; REVACCINATION; TIME; UNIVERSITY HOSPITAL; VACCINATION;

EID: 3042612188     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. de Vries B, Cossart YE. Needlestick injury in medical students. Med J Aust. 1994; 160: 398 - 400.
2. al-Sohaibani MO, al-Sheikh EH, al-Ballal SJ, Mirghani MA, Ramia S. Occupational risk of hepatitis B and C infections in Saudi medical staff. J Hosp Infect. 1995; 31: 143 - 7.
3. Diekema DJ, Ferguson KJ, Doebbeling BN. Motivation for hepatitis B vaccine acceptance among medical and physician assistant students. J Gen Intern Med. 1995; 10: 1 - 6.
4. Llewellyn LJ, Harvey I. Hepatitis B vaccination: how many doctors are fully covered ? J Public Health Med. 1994; 16: 352 - 6.
5. Dienstag JL , Werner BG , Polk F , Snydman DR, Craven DE, Platt R, et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med. 1984; 101: 34 - 40.
6. Peces R, Laures AS. Persistence of immunologic memory in long-term hemodialysis patients and healthcare workers given hepatitis B vaccine: role of a booster dose on antibody response. Nephron. 2001; 89: 172 - 6.
7. Marinho RT, Pedro M, Ramalho F, Velosa J, De Moura MC. Vaccine against hepatitis B. Eight years of experience [in Portuguese]. Acta Med Port. 1998; 11: 971 - 7.
8. Panizo Delgado A, Martinez Artola V. Hepatitis B vaccination: immunogenicity of the plasmatic vaccine in hospital personnel [in Spanish]. Med Clin (Barc). 1989; 92: 401 - 4.
9. Coursaget P, Yvonnet B, Gilks WR, Wang CC, Day NE, Chiron JP. Scheduling of revaccination against hepatitis B virus. Lancet. 1991; 337: 1180 - 3.
10. Simo Minana J, Gaztambide Ganuza M, Fernandez Millan P, Pena Fernandez M. Hepatitis B vaccine immunoresponsiveness in adolescents: a revaccination proposal after primary vaccination. Vaccine. 1996; 14: 103 - 6.
11. Chadha MS, Arankalle VA. Ten year serological follow up of hepatitis B vaccine recipients. Indian J Gastroenterol. 2000; 19: 168 - 71.
12. Sherlock S, Dooley J. Hepatitis B virus and hepatitis delta virus. In: Sherlock S, Dooley J, eds. Diseases of the Liver and Biliary System. 11th ed. Oxford: Blackwell Science; 2002: 285 - 300.
13. Merat S, Malekzadeh R, Rezvan H, Khatibian M. Hepatitis B in Iran. Arch Iranian Med. 2000; 3: 192 - 201.
14. Shakhgil'dian IV, Khukhlovich PA, Saving EA, Kuzin SN, Anan'ev VA, Sergeeva NA, et al. Risk of infection with hepatitis B and C viruses of medical workers, patients in the hemodialysis ward, and vaccine prophylaxis of hepatitis B infection in these populations [in Russian]. Vopr Virusol. 1994; 39: 226 - 9.
15. Ayerbe MC, Perez Rivilla A, ICOVAHB Group. Assesment of long-term efficacy of hepatitis B vaccine. Eur J Epidemiol. 2001; 17: 150 - 6.
16. Amini S, Andalibi S, Mahmoodi M. Anti-HBs response and its protective effect in children and adults receiving hepatitis B recombinant vaccine in Tehran. Iranian J Med Sci. 2002; 27: 101 - 5.
17. Shokrgozar MA, Shokri F. HLA-associated antibody response to recombinant hepatitis B vaccine in healthy Iranian adults. Iranian J Med Sci. 1999; 24: 98 - 103.